The case for & against
Bull & Bear analysis
Bearish
Enhabit, Inc. (NASDAQ: EHAB) is a prominent player in the home health care and hospice sectors, recognized for delivering essential services to patients with diverse medical needs. The company aims to leverage its scale and operational efficiencies while strategically navigating evolving regulatory environments and payer dynamics. Enhabit has a strong emphasis on enhancing its Medicare fee-for-service admissions while expanding its non-Medicare revenues through innovative payer contracts, positioning itself for growth in an increasingly complex healthcare landscape.
Bull says
- ↑Hospice segment revenue hit $63.1M in Q3, up 20% YoY with 25.3% Adj EBITDA margin
- ↑Non-Medicare admissions rose 10.4%, lifting non-Medicare revenue per visit by 7.6%
- ↑YTD free cash flow reached $27.8M; net debt/EBITDA leverage down to 3.9x
- ↑Outsourced coding rollout to deliver ~$1.5M in 2025 cost savings
- ↑2025 revenue guidance raised to $1.05–$1.08B reflecting volume momentum
- ↑Strong operational efficiency and payer innovation contracts underpin growth
Bear says
- ↓CMS’s proposed 6.4% home health rate cut could materially pressure revenues
- ↓Medicare patient volumes continue to decline, pressuring home health top line
- ↓Recent payer contract disruptions caused short-term volume and revenue declines
- ↓Execution risk in outsourced coding transition may disrupt service delivery
- ↓Regulatory and reimbursement pressures heighten leverage risk at 3.9x net debt/EBITDA
- ↓Inflationary cost pressures challenge margin sustainability amid rising expenses
Investment themes with EHAB
Demographics: Elderly Care↑ +0.43%
Services and products for aging population
ENSG · ACHC · SEM
Earnings Call · Q3 2024 · Mgmt. Guidance
Updated 09-14-2026neutral
Transcript signals
Bull points
- In our home health segment, our payer innovation strategy continues to foster non-Medicare growth.
- Non-Medicare admissions grew 20.1%, driving total admissions growth of 5.6% year over year, with 5.5% growth on a same store basis.
- We are pleased with the progress we've made with our revenue cycle management, and while no assurances can be provided, we expect our cash collection trends to continue to improve and result in a decrease in our reserve rate over time.
Bear points
- This decline in recertifications was the primary driver of the 9.9 million or 4.7% decrease in home health revenue year over year.
- Home health adjusted EBITDA decreased 5.3 million or 12.7% year-over-year primarily due to the decrease in revenue.
- will have all of that by our fourth quarter call.
Read full transcript analysis ›